Institute of Bioengineering and Bioimaging

The Institute of Bioengineering and Bioimaging (IBB) is located in Singapore's research and development hub for biomedical sciences, at the heart of Biopolis. The institute is located at Helios and Nanos and is staffed by imaging experts, bioengineers, chemists, physicists, biologists and clinicians.IBB integrates the capabilities and technologies built up by the Institute of Bioengineering and Nanotechnology (IBN) and Singapore Bioimaging Consortium (SBIC), which were established in 2003 and 2004 respectively. IBB's work includes the following scientific breakthroughs and innovations:

High-impact papers in leading scientific journals

Active patents under the Biomedical Research Council’s portfolio

10 spin-off companies (such as Lucence, InvitroCue and Respiree)

IBB's Vision

To be a world-leading Bioengineering and Bioimaging Institute focused on the translation of technologies for the benefit of human and society.

IBB's Mission

The Institute of Bioengineering & Bioimaging strives to develop new technologies and engineering solutions addressing health, medical and sustainability challenges and to promote the advancement of disease prevention, diagnosis and therapy. With our comprehensive research capabilities at the interface of physical sciences, engineering and bioimaging, the institute brings together multi-disciplinary teams of leading scientists and engineers to tackle national and international health and technological priorities through partnership with both clinical and industry communities.

Primary Activity

Material Manufacturer